Mn Services Vermogensbeheer B.V. grew its stake in STERIS plc (NYSE:STE – Free Report) by 1.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 38,600 shares of the medical equipment provider’s stock after acquiring an additional 700 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in STERIS were worth $7,935,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC bought a new stake in STERIS in the third quarter worth $25,000. Human Investing LLC bought a new stake in STERIS in the fourth quarter worth $31,000. Central Pacific Bank Trust Division boosted its holdings in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Manchester Capital Management LLC boosted its holdings in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 137 shares in the last quarter. Finally, Quarry LP bought a new stake in STERIS in the third quarter worth $67,000. 94.69% of the stock is owned by institutional investors.
STERIS Stock Down 0.4 %
STE stock opened at $219.23 on Friday. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The business’s 50-day moving average is $214.76 and its two-hundred day moving average is $223.11. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The company has a market cap of $21.54 billion, a price-to-earnings ratio of 46.54 and a beta of 0.84.
STERIS Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is 48.41%.
Wall Street Analyst Weigh In
STE has been the topic of several analyst reports. Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $258.75.
Get Our Latest Stock Report on STERIS
STERIS Company Profile
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Stories
- Five stocks we like better than STERIS
- How to Invest in the Best Canadian Stocks
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- How to Buy Cheap Stocks Step by Step
- 5 Best Gold ETFs for March to Curb Recession Fears
- 5 Top Rated Dividend Stocks to Consider
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.